ALTANA gets MHRA acceptance for Alvesco ALTANA AG has announced that the Medicines and Healthcare Items Regulatory Company in the United Kingdom has granted ALTANA Pharma advertising acceptance for Alvesco , a lung-activated inhaled corticosteroid with novel distribution and discharge properties. Alvesco is certainly indicated as prophylactic treatment of persistent asthma in adults. THE UK is usually serving as the Reference Member Condition for the European Mutual Recognition Procedure that’ll be initiated to get marketing acceptance for Alvesco in participating countries. This authorization of Alvesco in the united kingdom is another major milestone for ALTANA Pharma. Other approvals will follow, so that sufferers in many countries can reap the benefits of Alvesco..The 2015 recipients are: First place: Rutgers University Ernest Mario School of Pharmacy, with team members Danielle Tompkins, Alexander Mozeika, Ena Todorovska, Serena faculty and Arnouk advisor Saira A. Jan. The first place group’s school receives a $2,500 scholarship. Second place: Purdue University College of Pharmacy, with team members Hannah Han Le, Dong Helen Shao, Limin Zhang, Madeline Merkel and faculty advisor Amy Heck. The second place group’s college receives a $1,500 scholarship. Third Place: University of Minnesota College of Pharmacy, with associates Rebecca Pulk, Scott Baird, Mary Walter, Ryan Langem and faculty advisor Randall Seifert. The third place team’s school receives a $1,000 scholarship. The competition is backed by Genentech, Dymaxium and Amgen. Various other 2015 finalists represented Lipscomb University , Touro University , University of California at NORTH PARK, University of California at SAN FRANCISCO BAY AREA, and the University of Illinois at Chicago.